Ingevity Statistics
Total Valuation
Ingevity has a market cap or net worth of $1.90 billion. The enterprise value is $3.11 billion.
Important Dates
The last earnings date was Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ingevity has 35.96 million shares outstanding. The number of shares has increased by 0.22% in one year.
| Current Share Class | 35.96M |
| Shares Outstanding | 35.96M |
| Shares Change (YoY) | +0.22% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.50% |
| Owned by Institutions (%) | 103.21% |
| Float | 35.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 10.96 |
| PS Ratio | 1.39 |
| Forward PS | 1.43 |
| PB Ratio | 13.81 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.94 |
| P/OCF Ratio | 6.37 |
| PEG Ratio | 0.88 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.68, with an EV/FCF ratio of 12.99.
| EV / Earnings | n/a |
| EV / Sales | 2.25 |
| EV / EBITDA | 8.68 |
| EV / EBIT | 11.88 |
| EV / FCF | 12.99 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 9.35.
| Current Ratio | 1.27 |
| Quick Ratio | 0.63 |
| Debt / Equity | 9.35 |
| Debt / EBITDA | 3.40 |
| Debt / FCF | 5.39 |
| Interest Coverage | 3.06 |
Financial Efficiency
Return on equity (ROE) is -204.65% and return on invested capital (ROIC) is 10.23%.
| Return on Equity (ROE) | -204.65% |
| Return on Assets (ROA) | 8.10% |
| Return on Invested Capital (ROIC) | 10.23% |
| Return on Capital Employed (ROCE) | 18.42% |
| Revenue Per Employee | $863,813 |
| Profits Per Employee | -$41,188 |
| Employee Count | 1,600 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 4.01 |
Taxes
| Income Tax | -46.90M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.32% in the last 52 weeks. The beta is 1.40, so Ingevity's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | +11.32% |
| 50-Day Moving Average | 52.83 |
| 200-Day Moving Average | 47.00 |
| Relative Strength Index (RSI) | 55.19 |
| Average Volume (20 Days) | 301,193 |
Short Selling Information
The latest short interest is 1.02 million, so 2.82% of the outstanding shares have been sold short.
| Short Interest | 1.02M |
| Short Previous Month | 929,966 |
| Short % of Shares Out | 2.82% |
| Short % of Float | 2.84% |
| Short Ratio (days to cover) | 3.95 |
Income Statement
In the last 12 months, Ingevity had revenue of $1.38 billion and -$65.90 million in losses. Loss per share was -$1.82.
| Revenue | 1.38B |
| Gross Profit | 469.80M |
| Operating Income | 262.00M |
| Pretax Income | -407.70M |
| Net Income | -65.90M |
| EBITDA | 358.50M |
| EBIT | 262.00M |
| Loss Per Share | -$1.82 |
Full Income StatementBalance Sheet
The company has $83.40 million in cash and $1.29 billion in debt, giving a net cash position of -$1.21 billion or -$33.60 per share.
| Cash & Cash Equivalents | 83.40M |
| Total Debt | 1.29B |
| Net Cash | -1.21B |
| Net Cash Per Share | -$33.60 |
| Equity (Book Value) | 138.10M |
| Book Value Per Share | 3.83 |
| Working Capital | 110.60M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $298.60 million and capital expenditures -$59.00 million, giving a free cash flow of $239.60 million.
| Operating Cash Flow | 298.60M |
| Capital Expenditures | -59.00M |
| Free Cash Flow | 239.60M |
| FCF Per Share | $6.66 |
Full Cash Flow StatementMargins
Gross margin is 33.99%, with operating and profit margins of 18.96% and -4.77%.
| Gross Margin | 33.99% |
| Operating Margin | 18.96% |
| Pretax Margin | -29.50% |
| Profit Margin | -4.77% |
| EBITDA Margin | 25.94% |
| EBIT Margin | 18.96% |
| FCF Margin | 17.34% |
Dividends & Yields
Ingevity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.22% |
| Shareholder Yield | -0.22% |
| Earnings Yield | -3.46% |
| FCF Yield | 12.59% |
Dividend DetailsAnalyst Forecast
The average price target for Ingevity is $61.50, which is 16.24% higher than the current price. The consensus rating is "Buy".
| Price Target | $61.50 |
| Price Target Difference | 16.24% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | -1.20% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ingevity has an Altman Z-Score of 2.24 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.24 |
| Piotroski F-Score | 6 |